Dr. Henry Leis performs first-of-its-kind, minimally-invasive joint replacement for the hand and wrist

Ensemble Orthopedics, Inc. announced today the first implantation of the FDA-cleared Ensemble CMC™, the first implant in a product line of minimally invasive joint replacements for the hand and wrist. The surgery was performed by Henry T. Leis, M.D. on March 23, 2021 at Memorial Hospital–Gulf South Surgery Center in Gulfport, Mississippi.

The Ensemble CMC™ was designed to expand the treatment options for osteoarthritis of the carpometacarpal (CMC) joint to treat a broader range of patients using a minimally invasive, simple surgical procedure that offers the potential for shorter recovery times. Its proprietary saddle shape replaces the damaged bearing surfaces of the metacarpal and trapezium bones with an interpositional implant allowing for normal, pain-free motion. The implant is constructed using On-X® pyrocarbon – a high-strength, low-friction, biocompatible material which has shown superior wear resistance against bone when compared to metals or ceramic.

said Dr. Leis of Bienville Orthopaedic Specialists.

said William Ogilvie, President and CEO of Ensemble Orthopedics.

Ogilvie added.

Ensemble Orthopedics, a medical device company based in Austin TX, develops proprietary, interpositional implants designed to employ minimally invasive surgical techniques, thereby retaining stabilizing tendons and ligaments, for the treatment of arthritis in the hand and wrist.